Efficacy of Evolocumab in Monogenic Versus Polygenic Hypercholesterolemia

CJC Open - United States
doi 10.1016/j.cjco.2019.02.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Involvement of Human Monogenic Cardiomyopathy Genes in Experimental Polygenic Cardiac Hypertrophy

Physiological Genomics
GeneticsPhysiology
2018English

Clinical Evaluation of Evolocumab for the Treatment of Homozygous Familial Hypercholesterolemia in Chinese Patients

Therapeutics and Clinical Risk Management
2019English

Genome-Wide Analysis of Genetic Associations for Prediction of Polygenic Hypercholesterolemia With Bayesian Networks

Journal of Computational and Engineering Mathematics
2015English

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Efficacy of Targeted Screening for Childhood Hypercholesterolemia in Japan.

Kurume Medical Journal
Medicine
2001English

Pcv56 - Clinical and Economic Burden of Cardiovascular Disease and Value of Evolocumab Treatment in Patients With Heterozygous Familial Hypercholesterolemia in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia

American Journal of Cardiology
Cardiovascular MedicineCardiology
2013English

Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2017English

The Link Between Genetic Abnormalities in the Monogenic Disorders and the Behavioral Phenotype of Polygenic Disorders Has Yet to Be Addressed in Research

Autism - Open Access
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy